Clinical trial

IRAD2 : Patients With Respiratory Failure at Home

NCT00230984

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-04-01

PhasePHASE3

Study timeline

Study start (unknown)2003-04-01Date precision: month

Registry last updated2009-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Respiratory Failureunresolved

Nutritional Depletionunresolved

Interventions

educationBEHAVIORAL

Oral dietary supplements (563 kcal/d), RESPIFORDRUG

exercises on an ergometric bicycle 3 to 5 times a weekBEHAVIORAL

160 mg/d of oral testosterone undecanoate in men, 80 mg/d in womenDRUG

Sponsors & collaborators

University Hospital, Grenoblelead sponsor

Societe Francophone de Nutrition Enterale et Parenteralecollaborator

Association ANTADIR ,collaborator

Ministry of Health, Francecollaborator

Association AGIR à Dom,collaborator

Nutricia France, swizerland),collaborator

Organoncollaborator

Mapped research locations

ParisFrance1 MontpellierFrance1 RouenFrance1 PoitiersFrance1 LimogesFrance1 GenevaSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00230984 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.